Læknablaðið

Ukioqatigiit

Læknablaðið - 01.09.1979, Qupperneq 60

Læknablaðið - 01.09.1979, Qupperneq 60
198 LÆKNABLAÐIÐ tvívegis ræktast frá mönnum hér á landi, en það ár voru greind 4 alvarleg tilfelli af þess- um sjúkdómi og þykir því rétt að vekja at- hygli á honum. Tveir sjúklingar voru nýburar og greindist sjúkdómurinn skömmu eftir fæð- ingu og fengu börnin viðeigandi meðferð með góðum árangri. I einu tilviki var um að ræða fósturlát á 24. viku meðgöngu, en fjórði sjúklingurinn var 43 ára gamall maður með heilahimnubólgu, sem hugsanlega smitaðist af kindum. Sá sjúklingur ber varanleg merki sjúkdómsins. Listeria monocytogenes ræktaðist frá öll- um súklingunum og var bakteriologisk grein- ing framkvæmd á sýkladeild Rannsóknastofu Háskólans, en síðar staðfest af Center for Disease Control í USA. Þar voru stofnarnir einnig greindir serologiskt og reyndust allir vera af typu 4b. Tom Berganl Pharmacokinetics of metronidazole Metronidazole is an important drug for the treatment of certain protozoal and anaerobic bacterial infections. A cross over study has been done with several doses of tablets and suppositories. There is a linear relationship between dose and the surface under the serum concentration curves, both for the oral and the rectal dosages. The suppositories give serum levels which are some 80 per cent of the tablet responses. The serum half life varies betWeen 9-10 hours for unchanged metronidazole. Part of the drug is metabolized to partially antibacterially active derivatives. The serum half-life for total antibacterial activity is between 8 and 15 hours. l Departments of Microbiology, Aker sykehus and Institute of Pharmacy, University of Osio. M. Kjeld, Jeff Wieland, M. Puah. Progesterone conjugates in Human Urine Steroid hormones with hydroxylated func- tional groups are known to exist in conjugated forms in body fluids, primarily as glucuronides and sulphates. However it is generally felt that non-hydroxylated steroids are not con- jugated in body fluids. Past studies have dis- covered a so-called enol glucuronide in rat urine of androstendione ( a Keto-steroid) and enol glucuronides of androstenodione and pro- gesterone hav'e been synthesized. Such a con- jugate (enol) of progesterone has not been found in animals or humans. This fact, plus the observation that urinary progesterone levels are found to increase merely by leaving urine at room temperature led us to investi- gate possible conjugation of progesterone in urine. METHODS Urine from near term pregnant females was collected and then fractionated (into 30 fractions) on a Sephadex A-25 anion exchange column (30 cm x 0.5 cm). Fractions were then subjected to various treatments, followed by thin layer chromatography (TLC plates from Merck, 4/1 TOLUENE: Acetone solu- tion) and finally assayed by radio-immuno- assay for progesterone content. The treatment of fractions were as follows: 1) Untreated (control). 2) Acid hydrolysis for 16 hours with 3M h2so4. 3) Incubation for 16 hours at 37°C w/B- glucuronidase (400 phenothalein units in .5M Acetate buffer at pH 4.7). 4) Incubation for 16 hours at 37°C. Data: To be presented. Discussion: DATA suggest that progesterone is indeed conjugated in at least two forms’. The identity of these conjugates remains un- certain but the conjugates are both negatively charged and one appears to be mildly heat labile. Other studies have suggested that cer- tain tissues in steers have the ability to con- jugate progesterone and store progesterone in its coniugated form. This study supports this idea, that progesterone does exist physiologic- ally in conjugated forms, and goes further by showing that these conjugates of progesterone are found in human urine. The biological sign'ficance of these two new progesterone coniugates remains to be elucidated. These data further suggest that other non- hvdroxylated steroids should be re-evaluated for the possible existence of conjugates. Friðþjófur Björnsson, Ásbjörn Sigfússon, Tryggvi Ásmundsson Lyfja og geislameðferð við smá- frumukrabbameini í lunga Smáfrumulungnakrabbi er sú tegund lungnakrabbameins, sem er algengust hér á landi. Þessi tegund vex hraðast og sáir sér fliótt í önnur líffæri. Flestum læknum ber nú saman um, að hér eigi skurðlækningar ekki \'ið. Menn hafa náð umtalsverðum árangri síðiistu 5-6 ár með fleir-lyfja meðferð. Fiailað er um 11 siúklinga með smáfrumu- lungnakrabba. sem lögðust inn á deild III-B, Lsp., á 10 mán. tímabili. Meðferð var cyclo- \
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84
Qupperneq 85
Qupperneq 86
Qupperneq 87
Qupperneq 88
Qupperneq 89
Qupperneq 90
Qupperneq 91
Qupperneq 92
Qupperneq 93
Qupperneq 94
Qupperneq 95
Qupperneq 96

x

Læknablaðið

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið
https://timarit.is/publication/986

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.